The Surprising New Date That Could Fuel the AI Boom

Trump's economic blueprint is about to go live, and the deadline is fast-approaching. A new federal plan could legally unlock $100 trillion in U.S. resources... and one $10 stock could lead the charge. Former hedge fund manager Whitney Tilson explains how to act now, before this hits the headlines.

NVO
Novo Nordisk ADR
NYSE
45.38
Open 45.97 Prev Close 47.22
High 46.49 Low 45.05
Volume 37,438,114 Volume (Avg) 13,251
52 Week High 137.52 52 Week Low 45.05
Market Cap 152.8B PE Ratio 13.46

About Novo Nordisk ADR

Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally. It operates in two segments, Diabetes and Obesity Care, and Rare Disease. The Diabetes and Obesity care segment provides products for diabetes, obesity, cardiovascular, and other emerging therapy areas. The Rare Disease segment offers products in the areas of rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company also provides insulin pens, growth hormone pens, and injection needles. In addition, it offers smart solutions for diabetes treatment, such as smart insulin pens and Dose Check, an insulin dose guidance application. The company has a collaboration agreement with UNICEF to tackle childhood obesity; and with Valo Health, Inc. to discover and develop novel drug programmes for cardiometabolic space. Novo Nordisk A/S was founded in 1923 and is headquartered in Bagsvaerd, Denmark.

General

NameNovo Nordisk ADR
TickerNVO
ExchangeNYSE
SectorHealthcare
IndustryDrug Manufacturers - General
CurrencyUSD
CountryUSA
Fiscal Year EndDecember
Full Time Employees77,406

Highlights

Analyst Target77.06
Market Cap152,755,000,000
PE Ratio13.46
PEG Ratio1.23
EBITDA155,284,996,096

Share Stats

Shares Outstanding3,366,130,000
Shares Float3,366,070,000
Shares Short23,580,000
Insider Holdings1%
Institution Holdings9.81%

Highlights

Analyst Target77.06
Market Cap152,755,000,000
PE Ratio13.46
PEG Ratio1.23
EBITDA155,284,996,096

Valuation

Trailing PE12.94
Forward PE11.67
Price/Sales (Trailing 12 Mt.)0.71
Price/Book (Most Recent Quarter)9.75

Dividend

Novo Nordisk ADR pays out a dividend of $1.92 per share, with a dividend yield of 4.23%.

NVO's last dividend payment was made to shareholders on April 8, 2025.

They pay out 35.93% of their earnings out as a dividend.

Recent Dividends

Apr 8, 2025$1.10
Aug 26, 2024$0.52
Apr 2, 2024$0.93
Aug 29, 2023$0.44
Most Popular

Marjorie Taylor Greene Increases These 2 Stocks In Portfolio, Including This AI Name Up Over 100% YTD

Marjorie Taylor Greene has bought stocks multiple times in 2025 and her recent disclosure adds to one of the stocks that drew the biggest red flags in 2025.

How to Hack a $1.3T Market - Ad

Forget concrete. The new foundation for real estate success is digital, and Pacaso leads the way. Their tech unlocks a $1.3T real estate market. They've already earned $110M+ in gross profits in their operating history and reserved the Nasdaq ticker PCSO.

Mark Cuban Praised His 'Hustling' Son, But Told Kids: 'Figure Out Who You Are, You Don't Need To Follow In My Footsteps'

Jake Cuban embarked on an entrepreneurial journey reminiscent of his father's early business ventures by starting a side hustle selling candy at his school.

The Last Time This Warning Flashed, S&P 500 Crashed The Most Since 2008

A rare warning signal has reappeared in the market, with a low bull-bear spread and high investor indecision.

Trading Isn't Your Job. Let the System Handle It. - Ad

HiveMind AI handles trades for you-based on logic, not gut instinct. Built by pro traders. Runs 24/7. No emotions. No second-guessing. Want to deploy capital smarter?

Texas AG claimed three homes as primary residence. Democrats are being probed for similar issue

WASHINGTON (AP) — Texas Attorney General Ken Paxton and his wife, Angela, are longtime owners of a $1.5 million house in a gated community outside Dallas. In 2015, they snapped up a second home in Austin. Then another.

Back the Biotech Company Unlocking Mushroom Health Benefits for All - Ad

Functional mushrooms can boost mental, gut, and immune health-but people can't grow them at home. One company is making it easy with a patent-pending kitchen device. Think Nespresso, but for mushrooms. The functional mushroom market is projected to nearly double by 2030.

Is Elon's Empire Crumbling? - Ad

Jeff Brown - the legend who called Tesla and Nvidia early - says Elon is about to launch a $25T AI revolution. This isn't another chatbot. It's real-world AI that could 14X the impact of ChatGPT. But after October 23rd, it may be too late.

Is Costco Stock Topping Out? Key Price Levels To Watch

Costco stock (COST) may have formed a long-term peak. Adhishthana Principles suggest the next move could define the stock's future trajectory.

Nvidia's CEO Hits Beijing Like A Rockstar, Stirs Jensen-Mania In China

Nvidia CEO Jensen Huang receives a rockstar reception in Beijing during his most recent visit last week.

Back This Medical AI Tech - Ad

You don't often find healthcare tech company valued at $4M. HeartSciences is an exception. With $75M invested, including R&D, clinical trials, and product development, their patented AI software is approaching FDA submission, a potential major inflection point.

MicroStrategy's $14 Billion Bitcoin Gain Becomes A Footnote In Bold Treasury Vision

MicroStrategy Inc. (MSTR) shares down 6.15% as company reports Q2 revenue of $114.49M, beats estimates, and announces plan to transform into world's largest corporate treasury with increased bitcoin exposure and new capital strategy.

Elon Musk Changed His Number, Became Unreachable After Trump Feud, Reveals Speaker Mike Johnson: 'I Sent Him A Long Text Message, And Then...'

Tesla Inc. (NASDAQ: TSLA) CEO Elon Musk has reportedly changed his phone number following a fued with President Donald Trump and disagreement with Speaker Mike Johnson over the Republican's tax-and-spending bill.

Tap Into the $65B 'Shroom Boom' - Ad

People are rapidly discovering how mushrooms can enhance brain function, gut health, immunity, and more. The only thing holding them back? A simple way to grow them. Hypha Labs built a compact countertop device to solve exactly that.

What's in the Republican bill cutting $9 billion from public broadcasting and foreign aid

WASHINGTON (AP) — The Republican-led Congress is testing the popularity of spending cuts this week by aiming to pass President Donald Trump’s request to in public broadcasting and foreign aid spending.

Oklo Stock Hit A New 52-Week High Today: What's Driving The Action?

Shares of advanced nuclear technology company Oklo are trading higher Thursday. The company announced a strategic alliance with Liberty Energy on Wednesday.

FDA Submission Expected This Summer - Invest Before It Happens - Ad

This company is making heart disease easier to detect with AI. Their tech has officially been designated a "Breakthrough" by the FDA. You now have an opportunity to get in at a potential inflection point.

FDA Lifts Safety Hold On Sarepta's Muscular Dystrophy Gene Therapy—Wall Street Cheers

Sarepta stock sees upgrades and price hikes as analysts reassess Elevidys prospects following a favorable FDA development.

Retirees, here’s how to tweak the 4% rule to protect your nest egg

New retirees might enter a different environment than their predecessors—the economy or market might have changed slightly or dramatically.

Smarter Capital. No Screens. No Noise. - Ad

HiveMind AI handles trades for you-based on logic, not gut instinct. Built by pro traders. Runs 24/7. No emotions. No second-guessing. Want to deploy capital smarter?

Semiconductor Stocks React To Key Policies And Earnings

Semiconductor chip companies, including Nvidia, AMD, Broadcom, Marvell Tech, and Super Micro had a volatile week due to trade policies and earnings.

AMD Rises To 1-Year Highs, Crude Eyes $68: What's Moving Markets Tuesday?

Risk appetite took a breather Tuesday, with major U.S. stock indices retreating modestly from record highs as investors braced for a pivotal stretch of earnings and macro events.

Better Than Bitcoin? (Top Crypto for Less Than $1) - Ad

Over the past 15 years, Bitcoin has outperformed stocks, bonds, and every other asset you could've bought. 2025 is already shaping up to be another banner year, with Bitcoin recently hitting a new all-time high. But there's a better way to profit from this new crypto rally. Most people don't know about it... and yet it's returned over 1,000% in 4 months. This could be the #1 way to invest in crypto right now.

Tim Walz: Trump 'Brings Out the Worst in Me'

Gov. Tim Walz (D-Minn.) offered a candid reflection on his rhetoric toward Donald Trump, acknowledging regret over earlier inflammatory comments made during the 2024 presidential campaign.

Kraken Aims To Raise $500 Million, Second-Largest US Crypto Platform Eyeing A $15 Billion Valuation: Report

Cryptocurrency exchange, Kraken, is planning to raise $500 million in funding, a move that could push its valuation to $15 billion, according to a report published Tuesday.

The Surprising New Date That Could Fuel the AI Boom - Ad

Trump's economic blueprint is about to go live, and the deadline is fast-approaching. A new federal plan could legally unlock $100 trillion in U.S. resources... and one $10 stock could lead the charge. Former hedge fund manager Whitney Tilson explains how to act now, before this hits the headlines.

Decade-Old Bitcoin Wallet Emptied, Millions in BTC Moved Amid Market Correction

A Bitcoin (CRYPTO: BTC) wallet that has been inactive for over a decade was emptied on Friday, marking a significant movement in the cryptocurrency market.

How Palantir, Tempus, Nvidia-Backed Recursion Are Disrupting Big Pharma

AI-native players like Palantir, Tempus, and Recursion are disrupting drug discovery and attracting investors, while Big Pharma struggles.

How to Hack a $1.3T Market - Ad

Forget concrete. The new foundation for real estate success is digital, and Pacaso leads the way. Their tech unlocks a $1.3T real estate market. They've already earned $110M+ in gross profits in their operating history and reserved the Nasdaq ticker PCSO.

Trump administration appeals to Supreme Court to allow $783 million research-funding cuts

WASHINGTON (AP) — The Trump administration asked the on Thursday to allow it to cut hundreds of millions of dollars’ worth of research funding in its push to roll back federal diversity, equity and inclusion efforts.

Why Spotify's Latest Results Look Worse Than They Are

Spotify (SPOT) stock drops after missing earnings and revenue expectations, despite strong user growth. Analysts maintain Overweight and Buy ratings.

Trading Isn't Your Job. Let the System Handle It. - Ad

HiveMind AI handles trades for you-based on logic, not gut instinct. Built by pro traders. Runs 24/7. No emotions. No second-guessing. Want to deploy capital smarter?

Federal Reserve likely to stand pat on rates this week, deepening the gulf between Powell and Trump

WASHINGTON (AP) — The Federal Reserve is expected to leave its short-term interest rate unchanged on Wednesday for the fifth straight meeting, a move that will likely underscore between how Chair Jerome Powell and his chief critic, President Donald Trump, see the economy.

Federal Reserve Governor Adriana Kugler Resigns, Handing Trump A Key Vacancy Ahead Of Powell's Term End

Adriana Kugler, a Fed governor, will step down on Aug 8. Her exit may affect Fed leadership succession amid Trump's tensions with Powell.

Back the Biotech Company Unlocking Mushroom Health Benefits for All - Ad

Functional mushrooms can boost mental, gut, and immune health-but people can't grow them at home. One company is making it easy with a patent-pending kitchen device. Think Nespresso, but for mushrooms. The functional mushroom market is projected to nearly double by 2030.

Bitcoin Could Explode to $136,000 if This Happens, Says Analytics Firm

In a recent prediction by analytics platform Glassnode, Bitcoin‘s (CRYPTO: BTC) value could potentially surge by roughly 15%, reaching a staggering $136,000, if current demand continues. However, there is a possible hitch to this prediction.

Most Recent

Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.

Copyright systemtrading.ca
Privacy Policy | Terms of Service